{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:08:07Z","timestamp":1790996887244,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.clindermatol.2013.05.024","type":"journal-article","created":{"date-parts":[[2013,12,7]],"date-time":"2013-12-07T13:27:11Z","timestamp":1386422831000},"page":"35-46","source":"Crossref","is-referenced-by-count":58,"title":["Rosacea and rhinophyma"],"prefix":"10.1016","volume":"32","author":[{"given":"Yal\u00e7\u0131n","family":"T\u00fcz\u00fcn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronni","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekayi","family":"Kutlubay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"Karaku\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burhan","family":"Engin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2013.05.024_bb0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000082564","article-title":"Rosacea: an update","volume":"210","author":"Buechner","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","article-title":"Rosacea: etiology, pathogenesis, and subtype classification","volume":"51","author":"Crawford","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0015","first-page":"435","article-title":"Rosacea: a common, yet commonly overlooked, condition","volume":"66","author":"Blount","year":"2002","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1542-2011.2011.00156.x","article-title":"Rosacea","volume":"57","author":"Fuller","year":"2012","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0025","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2133.2012.11037.x","article-title":"A study on the epidemiology of rosacea in the U.K","volume":"167","author":"Spoendlin","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2340\/00015555-0856","article-title":"Prevalence of rosacea in an Estonian working population using a standard classification","volume":"90","author":"Abram","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0035","first-page":"19","article-title":"Rosacea","volume":"3","author":"Erdem","year":"2012","journal-title":"Dermatose"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0040","first-page":"16","article-title":"Advances in understanding and managing rosacea, part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema","volume":"5","author":"Del Rosso","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1468-3083.2010.03751.x","article-title":"Rosacea-global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group","volume":"25","author":"Elewski","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2009.04.007","article-title":"The molecular pathology of rosacea","volume":"55","author":"Yamasaki","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00403-007-0816-z","article-title":"A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process","volume":"300","author":"Aroni","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/bjo.2006.101121","article-title":"Expression of vascular endothelial growth factor and its receptors in rosacea","volume":"91","author":"Smith","year":"2007","journal-title":"Br J Ophtalmol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0065","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1600-0560.2006.00695.x","article-title":"Lymphangiogenesis and angiogenesis in non-phymatous rosacea","volume":"34","author":"Gomaa","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5021\/ad.2012.24.2.126","article-title":"Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease","volume":"24","author":"Reinholz","year":"2012","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0075","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1468-3083.2009.03424.x","article-title":"Clinical and laboratory study of rosacea in Northern Greece","volume":"24","author":"Lazaridou","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jaad.2008.10.014","article-title":"Oxidative stress and ferritin expression in the skin of patients with rosacea","volume":"60","author":"Tisma","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2230.2003.01179.x","article-title":"The role of free oxygen radicals in the aetiopathogenesis of rosacea","volume":"28","author":"\u00d6ztas","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1610-0387.2010.07513.x","article-title":"The potential role of microorganisms in the development of rosacea","volume":"9","author":"Lazaridou","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0095","first-page":"896","article-title":"Retrospective analysis of the association between Demodex infestation and rosacea","volume":"146","author":"Zhao","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/sder.2001.27553","article-title":"Rosacea: current thoughts on origin","volume":"20","author":"Bamford","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1684\/ejd.2009.0739","article-title":"Helicobacter pylori infection and dermatologic diseases","volume":"19","author":"Hernando-Harderac","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-3083.2009.03472.x","article-title":"Risk factors associated with rosacea","volume":"24","author":"Abram","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0115","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1468-3083.2010.03802.x","article-title":"Prevalence analysis of smoking in rosacea","volume":"25","author":"Breton","year":"2011","journal-title":"J Eur Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0120","unstructured":"Culp B, Scheinfeld N. Rosacea: a review. P T. 2009;34:38-45."},{"issue":"Suppl. 3","key":"10.1016\/j.clindermatol.2013.05.024_bb0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0151-9638(11)70089-8","article-title":"Clinical presentation and classification of rosacea","volume":"138","author":"Jansen","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMcp042829","article-title":"Clinical practice. Rosacea","volume":"352","author":"Powell","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0135","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaad.2004.01.048","article-title":"Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.clindermatol.2013.05.024_bb0140","first-page":"71201a","article-title":"The role of contact allergy in rosacea","volume":"1","author":"\u00c7akmak","year":"2007","journal-title":"J Turk Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5021\/ad.2009.21.3.243","article-title":"Clinical evaluation of 168 Korean patients with rosacea: the sun exposure correlates with the erythematotelangiectatic subtype","volume":"21","author":"Bae","year":"2009","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2009.04.024","article-title":"Papulopustular rosacea: prevalence and relationship to photodamage","volume":"63","author":"McAleer","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0155","first-page":"26","article-title":"Advances in understanding and managing rosacea, part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea","volume":"5","author":"Del Rossa","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaad.2009.12.036","article-title":"Staphylococcus epidermidis: a possible role in the pustules of rosacea","volume":"64","author":"Whitfeld","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0165","series-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Wolff","year":"2007"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clindermatol.2010.07.009","article-title":"Rosacea and rhinophyma in elderly","volume":"29","author":"Wollina","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0175","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0190-9622(97)80389-1","article-title":"Periorbital edema as an initial presentation of rosacea","volume":"37","author":"Chen","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.optm.2010.01.015","article-title":"Rosacea and its ocular manifestations","volume":"82","author":"Oltz","year":"2011","journal-title":"Optometry"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0185","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4103\/0378-6323.53146","article-title":"Correlation of the severity of cutaneous rosacea with ocular rosacea","volume":"75","author":"Keshtcar-Jafari","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/DAD.0b013e31815cd937","article-title":"Otopyhma: a case report and review of the literature of lymphedema (elephantiasis) of the ear","volume":"30","author":"Carlson","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0195","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-4362.2003.01780.x","article-title":"Measuring the severity of rosacea: a review","volume":"42","author":"Gessert","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0200","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00266-011-9802-0","article-title":"Malignancies within rhinophyma: report of three new cases and review of the literature","volume":"36","author":"Lazeri","year":"2012","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0205","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-4632.2007.03360.x","article-title":"Rosacea with extensive extrafacial lesions","volume":"47","author":"Pereira","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0210","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1365-2133.2010.09880.x","article-title":"Rosacea fulminans with ocular involvement","volume":"163","author":"Kim","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0215","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2133.2004.06190.x","article-title":"Rosacea fulminans in pregnancy","volume":"151","author":"Lewis","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0220","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000324226","article-title":"A case of acne fulminans in a patient with ulcerative colitis successfully treated with prednisolone and diaminodiphenylsulfone: a review of acne fulminans, rosacea fulminans and neutrophilic dermatoses occuring in the setting of inflammatory bowel disease","volume":"222","author":"Wakayashi","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0225","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2340\/00015555-0039","article-title":"Rosacea fulminans related to pegylated interferon alpha-2b and ribavirin therapy","volume":"86","author":"Bettoli","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0230","series-title":"Pathology of the Skin with Clinical Correlations","first-page":"1121","author":"McKee","year":"2005"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0235","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1440-0960.2009.00557.x","article-title":"Childhood ocular rosacea: considerations for diagnosis and treatment","volume":"50","author":"Hong","year":"2009","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0240","first-page":"214","article-title":"Diagnosis and treatment of rosacea","author":"Cohen","year":"2002","journal-title":"J Am Board Fam Pract"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0245","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2004.03.033","article-title":"Rosacea: II therapy","volume":"51","author":"Pelle","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0250","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1468-3083.2005.01216.x","article-title":"Rosacea and its management: an overview","volume":"19","author":"Gupta","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0255","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1468-3083.2009.03167.x","article-title":"Current topical and systemic approaches to treatment of rosacea","volume":"23","author":"Korting","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0260","first-page":"20","article-title":"Comprehensive medical management of rosacea: an interim study report and literature review","volume":"1","author":"Del Rosso","year":"2008","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0265","first-page":"1","article-title":"Rosacea and its topical management","volume":"14","author":"Gooderham","year":"2009","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0270","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(99)70085-X","article-title":"A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea","volume":"40","author":"Maddin","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0275","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/archderm.139.11.1444","article-title":"A comparison of 15% azelaic acid and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomised trial","volume":"139","author":"Elewski","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0280","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2005.04.069","article-title":"A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20 mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea","volume":"53","author":"Sanchez","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0285","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2133.2011.10473.x","article-title":"Effective and evidence-based strategies for rosacea: summary of a Cochrane systematic review","volume":"165","author":"van Zuuren","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0290","first-page":"461","article-title":"Treatment options for acne rosacea","volume":"80","author":"Goldgar","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0295","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-4632.2005.02769.x","article-title":"Azelaic acid (15% gel) in the treatment of acne rosacea","author":"Gupta","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0300","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-3083.2008.02940.x","article-title":"Comparative study of some treatment modalities of rosacea","volume":"23","author":"Mostafa","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1529-8019.2012.01497.x","article-title":"New antibiotic therapies for acne and rosacea","volume":"25","author":"Mays","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0310","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-4632.2004.02130.x","article-title":"Adapalene vs metronidazole gel for the treatment of rosacea","volume":"44","author":"Alt\u0131nyazar","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0315","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/0019-5154.77547","article-title":"Steroid-induced rosacea: a clinical study of 200 patients","volume":"56","author":"Bhat","year":"2011","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0320","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2133.2006.07669.x","article-title":"Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial","volume":"156","author":"Weissenbacher","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0325","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-3083.2008.02589.x","article-title":"A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea","volume":"22","author":"Karabulut","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0330","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2008.08496.x","article-title":"Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split face clinical trial","volume":"158","author":"Lee","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0335","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2133.2005.06404.x","article-title":"The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea","volume":"152","author":"Chu","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/00015550510043975","article-title":"Pimecrolimus cream 1% is effective in a case of granulomatous rosacea","volume":"86","author":"Cunha","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0345","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archderm.143.11.1369","article-title":"Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor","volume":"143","author":"Shanler","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0350","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2011.10716.x","article-title":"Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies","volume":"166","author":"Fowler","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0355","first-page":"1","article-title":"Systemic therapy for rosacea","volume":"12","author":"Baldwin","year":"2007","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0360","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1610-0387.2011.07723.x","article-title":"Treatment of ocular rosacea with 40 mg doxycycline in a slow release form","volume":"9","author":"Pfeffer","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0365","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3346\/jkms.2011.26.5.694","article-title":"Oral azithromycin for the treatment of intractable rosacea","volume":"26","author":"Kim","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0370","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-4632.2008.03445.x","article-title":"Comparison of efficacy of azithromycin vs doxycycline in the treatment of rosacea: a randomized open clinical trial","volume":"47","author":"Akhyani","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0375","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2230.2006.02322.x","article-title":"The effect of azithromycin on reactive oxygen species in rosacea","volume":"32","author":"Bakar","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0380","series-title":"Treatment of Skin Disease Comprehensive Therapeutic Strategies","first-page":"669","author":"Lebwohl","year":"2009"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0385","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaad.2006.04.084","article-title":"Systematic review of rosacea treatments","volume":"56","author":"van Zuuren","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0390","first-page":"54","article-title":"Use of isotretinoin in the management of rosacea","volume":"4","author":"Park","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0395","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1610-0387.2010.07345.x","article-title":"Systemic isotretinoin in the treatment of rosacea-doxycycline and placebo-controlled, randomized clinical study","volume":"8","author":"Gollnick","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0400","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2340\/00015555-1204","article-title":"Rosacea treatment with intermediate-dose isotretinoin: follow-up with erythema and sebum measurements","volume":"92","author":"Uslu","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0405","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-4632.2006.02944.x","article-title":"Oral zinc sulfate in the treatment of rosacea: a double blind, placebo-controlled study","volume":"45","author":"Sharquie","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0410","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-4632.2011.05353.x","article-title":"Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea","volume":"51","author":"Bamford","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0415","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clindermatol.2005.10.026","article-title":"Laser treatment of vascular lesions","volume":"24","author":"Railan","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0420","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0378-6323.79728","article-title":"Lasers for vascular lesions: standard guidelines of care","volume":"77","author":"Srinivas","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0425","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bjps.2004.02.011","article-title":"Pulsed dye laser therapy for rosacea","volume":"57","author":"Tan","year":"2004","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0430","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2004-822963","article-title":"Use of the KTP laser in the treatment of rosacea and solar lentigines","volume":"20","author":"Bassichis","year":"2004","journal-title":"Facial Plast Surg"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0435","first-page":"760","article-title":"Treatment of erythematotelangiectatic rosacea with a KTP YAG laser","volume":"4","author":"Miller","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0440","first-page":"254","article-title":"Treatment of rosacea with intense pulsed light","volume":"2","author":"Taub","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0445","first-page":"37","article-title":"Successful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequency","volume":"1","author":"Taub","year":"2008","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0450","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1524-4725.2005.31204","article-title":"Effective treatment of rosacea using intense pulsed light systems","volume":"31","author":"Schroeter","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0455","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1524-4725.2003.29141.x","article-title":"Objective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatment","volume":"29","author":"Mark","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0460","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2340\/00015555-0976","article-title":"Rhinophyma: big problem, simple solution","volume":"91","author":"Rordam","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0465","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1524-4725.2002.02013.x","article-title":"Excision of rhinophyma with high-frequency electrosurgery","volume":"28","author":"Aferzon","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0470","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/lsm.1112","article-title":"Treatment of rhinophyma with Er:YAG laser","volume":"29","author":"Orenstein","year":"2001","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.clindermatol.2013.05.024_bb0475","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1440-0960.2009.00561.x","article-title":"Rhinophyma: carbon dioxide laser with computerized scanner is still an outstanding treatment","volume":"50","author":"Lim","year":"2009","journal-title":"Australas J Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13000916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13000916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T20:38:57Z","timestamp":1688848737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X13000916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0738081X13000916"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2013.05.024","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}